Annual Shareholders Equity
$411.00 K
-$4.39 M-91.44%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual stockholders equity is $411.00 thousand, with the most recent change of -$4.39 million (-91.44%) on December 31, 2023.
- During the last 3 years, VVOS annual shareholders equity has fallen by -$16.51 million (-97.57%).
- VVOS annual shareholders equity is now -98.39% below its all-time high of $25.54 million, reached on December 31, 2021.
Performance
VVOS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$7.67 M
+$1.32 M+20.77%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly stockholders equity is $7.67 million, with the most recent change of +$1.32 million (+20.77%) on September 30, 2024.
- Over the past year, VVOS quarterly shareholders equity has stayed the same.
- VVOS quarterly shareholders equity is now -78.99% below its all-time high of $36.48 million, reached on June 30, 2021.
Performance
VVOS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VVOS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -91.4% | 0.0% |
| 3 y3 years | -97.6% | -76.4% |
| 5 y5 years | -91.5% | -46.5% |
VVOS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.4% | at low | -70.0% | >+9999.0% |
| 5 y | 5-year | -98.4% | +114.0% | -79.0% | +360.4% |
| alltime | all time | -98.4% | +114.0% | -79.0% | +360.4% |
Vivos Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.67 M(+20.8%) |
| Jun 2024 | - | $6.35 M(+990.5%) |
| Mar 2024 | - | $582.00 K(+41.6%) |
| Dec 2023 | $411.00 K(-91.4%) | $411.00 K(+793.5%) |
| Sep 2023 | - | $46.00 K(-97.8%) |
| Jun 2023 | - | $2.11 M(-69.9%) |
| Mar 2023 | - | $6.99 M(+45.7%) |
| Dec 2022 | $4.80 M | $4.80 M(-51.3%) |
| Sep 2022 | - | $9.86 M(-33.6%) |
| Jun 2022 | - | $14.84 M(-28.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $20.86 M(-18.3%) |
| Dec 2021 | $25.54 M(+51.0%) | $25.54 M(-21.3%) |
| Sep 2021 | - | $32.47 M(-11.0%) |
| Jun 2021 | - | $36.48 M(+154.4%) |
| Mar 2021 | - | $14.34 M(-15.2%) |
| Dec 2020 | $16.92 M(-674.8%) | $16.92 M(-978.2%) |
| Sep 2020 | - | -$1.93 M(-12.6%) |
| Jun 2020 | - | -$2.20 M(-25.1%) |
| Dec 2019 | -$2.94 M(-161.0%) | -$2.94 M |
| Dec 2018 | $4.83 M | - |
FAQ
- What is Vivos Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Vivos Therapeutics?
- What is Vivos Therapeutics annual shareholders equity year-on-year change?
- What is Vivos Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly shareholders equity year-on-year change?
What is Vivos Therapeutics annual stockholders equity?
The current annual shareholders equity of VVOS is $411.00 K
What is the all time high annual shareholders equity for Vivos Therapeutics?
Vivos Therapeutics all-time high annual stockholders equity is $25.54 M
What is Vivos Therapeutics annual shareholders equity year-on-year change?
Over the past year, VVOS annual stockholders equity has changed by -$4.39 M (-91.44%)
What is Vivos Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of VVOS is $7.67 M
What is the all time high quarterly shareholders equity for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly stockholders equity is $36.48 M
What is Vivos Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, VVOS quarterly stockholders equity has changed by $0.00 (0.00%)